August 29, 2016
Amidst a growing furor over the skyrocketing price of the EpiPen (an auto-injecting epinephrine administrator used by people with life-threatening allergies), Mylan (the manufacturer of the device) has expanded its financial assistance program. Many question whether these coupons will be enough to counteract the backlash Mylan is currently receiving, online and in Congress.
Although prices for the device have been steadily and steeply climbing for years, these increased prices have recently come to the forefront with higher deductibles and out-of-pocket costs for users of the device. Many link the drug’s price hike to the imminent arrival of a generic version.